Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Allison Berger"'
Autor:
Jill Donelan, Stephen Tirrell, Erik Koenig, Bradley Stringer, Kristen Jordan, Cindy Q. Xia, Mark Manfredi, Allison Berger, Yu Yang, Angel Maldonado Lopez, James Garnsey, Nelson Rhodes, Katherine Galvin, Ben Amidon, Paul Hales, Nibedita Chattopadhyay, Hugues Bernard, Bret Bannerman, Greg Hather
Publikováno v:
PLoS ONE, Vol 10, Iss 12, p e0144825 (2015)
PLoS ONE
PLoS ONE
In non-clinical studies, the proteasome inhibitor ixazomib inhibits cell growth in a broad panel of solid tumor cell lines in vitro. In contrast, antitumor activity in xenograft tumors is model-dependent, with some solid tumors showing no response to
Autor:
Paul G. Richardson, Alessandra Di Bacco, Andrew Dorner, Allison Berger, Deborah Ricci, Pieter Sonneveld, Erik Koenig, Robert Z. Orlowski, Jeśus F.San Miguel, Hugues Bernard, Edward A. Stadtmauer, William L. Trepicchio, David I. Lichter, Helgi van de Velde, Sundar Jagannath, Matthew Schu, Kenneth C. Anderson, Stephen J. Blakemore, Nibedita Chattopadhyay, Dixie Lee Esseltine, George Mulligan, Joseph B. Bolen, Rachel Neuwirth, Bin Li, Sagar Lonial, James R. Berenson
Publikováno v:
Blood, 123(5), 632-639. American Society of Hematology
Various translocations and mutations have been identified in myeloma, and certain aberrations, such as t(4;14) and del17, are linked with disease prognosis. To investigate mutational prevalence in myeloma and associations between mutations and patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdc7a06d9996ee11f17c51fcbb70b586
https://europepmc.org/articles/PMC4123425/
https://europepmc.org/articles/PMC4123425/
Autor:
Hugues Bernard, James J. Garnsey, Erik Koenig, Ben Amidon, Allison Berger, Eric S. Lightcap, Nibedita Chattopadhyay
Publikováno v:
Molecular Cancer Therapeutics. 12:B156-B156
The investigational proteasome inhibitor ixazomib (MLN2238) inhibits cell growth in a broad panel of solid tumor and hematological cell lines when tested in vitro. In contrast, antitumor activity in xenograft-bearing mice is model-dependent, with som